M&A Deal Summary

Grupo Biotoscana Acquires Laboratorio DOSA SA

On November 13, 2017, Grupo Biotoscana acquired life science company Laboratorio DOSA SA for 30M USD

Acquisition Highlights
  • This is Grupo Biotoscana’s 1st transaction in the Life Science sector.
  • This is Grupo Biotoscana’s largest (disclosed) transaction.
  • This is Grupo Biotoscana’s 1st transaction in Argentina.

M&A Deal Summary
Date 2017-11-13
Target Laboratorio DOSA SA
Sector Life Science
Buyer(s) Grupo Biotoscana
Deal Type Add-on Acquisition
Deal Value 30M USD

Target

Laboratorio DOSA SA

Argentina
Laboratorio DOSA SA is a specialty pharmaceutical manufacturer. Laboratorio DOSA is based in Argentina.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Grupo Biotoscana

Montevideo, Uruguay
Category Company
Founded 2011
Sector Life Science
DESCRIPTION

Biotoscana Investments SA is a biopharmaceutical group that operates in the fast-growing Latin American region and focuses on rapidly growing market segments such as infectious diseases, oncology and onco-hematology, special treatments, immunology and inflammation, and orphan/rare diseases, among others. Biotoscana Investments was founded in 2011 and is based in Montevideo, Uruguay.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (Argentina) 1 of 1
Year (2017) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal